A practical guide to targeted therapy for bone pain palliation

被引：5
|
作者：
Lewington, VJ [1 ]
机构：
[1] Southampton Univ Hosp NHS Trust, Dept Nucl Med, Southampton SO16 6YD, Hants, England
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 2002年 / 23卷 / 09期
关键词：
metastasis; bone pain; targeted therapy; strontium-89; chloride; rhenium-186; HEDP; samarium-153; EDTMP; dose rate; myelosuppression;
D O I：
10.1097/00006231-200209000-00004
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Targeted radionuclide therapy is an effective and cost efficient treatment for multi-site metastatic bone pain. This paper discusses the physical characteristics of the licensed radiopharmaceuticals Sm-153 ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) (Sm-153-EDTMP), Re-186 1,1-hydroxyethylidenediphosphonate (Re-186-HEDP) and (SrCl2)-Sr-89 and considers the factors influencing treatment choice in specific clinical settings. The advantages and practical limitations of this approach are discussed, with emphasis on defining criteria for patient selection and response monitoring. Opportunities for future research and development are outlined. ((C) 2002 Lippincott Williams Wilkins).
引用
收藏
页码：833 / 836
页数：4
相关论文
共 50 条
  • [21] Radiopharmaceutical therapy for palliation of bone pain from osseous Metastases: what about beta Therapy in prostate cancer?
    Ben Ghachem, T.
    Mhiri, A.
    Slim, I.
    Yeddes, I.
    Elbez, I.
    Meddeb, I.
    Sellem, A.
    Hammami, H.
    Ben Slimene, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S740 - S740
  • [22] Lu-177-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
    Balter, Henia
    Victoria, Trindade
    Mariella, Teran
    Javier, Gaudiano
    Rodolfo, Ferrando
    Andrea, Paolino
    Graciela, Rodriguez
    Juan, Hermida
    Eugenia, De Marco
    Patricia, Oliver
    CURRENT RADIOPHARMACEUTICALS, 2016, 9 (01) : 85 - 93
  • [23] Efficacy of Sm-153 Radionuclide Therapy for Bone Pain Palliation in Metastatic Prostate Cancer
    Incili, N.
    Gumus, B.
    Parlak, Y.
    Gumuser, G.
    Yuksel, M. Bigehan
    Sayit, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S401 - S401
  • [24] Impact of timing of administration of bone supportive therapy on pain palliation from radium-223.
    Yap, Kelly Khai Li
    Wong, William
    Ji, Lingyun
    Groshen, Susan G.
    Quinn, David I.
    Pinski, Jacek K.
    Bryce, Alan Haruo
    Dorff, Tanya B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases
    Liepe, K.
    Murray, I
    Flux, G.
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) : 178 - 190
  • [26] RADIONUCLIDE PALLIATION OF CANCER-RELATED BONE PAIN
    MAXON, HR
    SCHRODER, LE
    THOMAS, SR
    DEUTSCH, ED
    LIBSON, KF
    MOULTON, JS
    WILLIAMS, CC
    HERTZBERG, VS
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (12) : 2027 - 2027
  • [27] Yb-175-TTHMP for bone pain palliation
    Tin, Sim Sai
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (01): : 90 - 90
  • [28] Practical Guide to Laparoscopic Pain Mapping
    Yunker, Amanda
    Steege, John
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2010, 17 (01) : 8 - 11
  • [29] Neuropathic pain: a practical guide for the clinician
    Gilron, Ian
    Watson, C. Peter N.
    Cahill, Catherine M.
    Moulin, Dwight E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (03) : 265 - 275
  • [30] Immunophenotyping as a guide for targeted therapy
    Sonneveld, P
    Pieters, R
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (04) : 629 - 644
12345